NCT00301834 2017-09-28
Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
University of California, San Francisco
Phase 2 Completed
University of California, San Francisco
University of California, San Francisco